These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36121608)
41. A Lesson from the Green Pass Experience in Italy: A Narrative Review. Campanozzi LL; Tambone V; Ciccozzi M Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146561 [TBL] [Abstract][Full Text] [Related]
42. Emphasizing truthfulness in COVID-19 test declarations. Gozum IEA; Carreon ADV; Manansala MM J Public Health (Oxf); 2021 Jun; 43(2):e387-e388. PubMed ID: 33782683 [TBL] [Abstract][Full Text] [Related]
43. COVID-19 vaccination certificate (CVC) for ASEAN: the way forward? Corpuz JCG J Public Health (Oxf); 2022 Jun; 44(2):e289-e290. PubMed ID: 34109396 [TBL] [Abstract][Full Text] [Related]
44. Medical Liability of the Vaccinating Doctor: Comparing Policies in European Union Countries during the COVID-19 Pandemic. Amantea C; Rossi MF; Santoro PE; Beccia F; Gualano MR; Borrelli I; da Costa JP; Daniele A; Tumminello A; Boccia S; Ricciardi W; Moscato U Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742438 [TBL] [Abstract][Full Text] [Related]
45. Why 'one size fits all' is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey. Niculaescu CE; Sassoon I; Landa-Avila IC; Colak O; Jun GT; Balatsoukas P BMJ Open; 2022 Apr; 12(4):e058317. PubMed ID: 35428643 [TBL] [Abstract][Full Text] [Related]
46. Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA. Suk JE; Pharris A; Beauté J; Colzani E; Needham H; Kinsman J; Niehus R; Grah R; Omokanye A; Plachouras D; Baka A; Prasse B; Sandmann F; Severi E; Alm E; Wiltshire E; Ciancio B Euro Surveill; 2022 Apr; 27(17):. PubMed ID: 35485272 [TBL] [Abstract][Full Text] [Related]
47. Practices and Attitudes of Bavarian Stakeholders Regarding the Secondary Use of Health Data for Research Purposes During the COVID-19 Pandemic: Qualitative Interview Study. McLennan S; Rachut S; Lange J; Fiske A; Heckmann D; Buyx A J Med Internet Res; 2022 Jun; 24(6):e38754. PubMed ID: 35696598 [TBL] [Abstract][Full Text] [Related]
48. Vaccine passports and health disparities: a perilous journey. Jecker NS J Med Ethics; 2022 Dec; 48(12):957-960. PubMed ID: 34244344 [TBL] [Abstract][Full Text] [Related]
49. Digital tools against COVID-19: taxonomy, ethical challenges, and navigation aid. Gasser U; Ienca M; Scheibner J; Sleigh J; Vayena E Lancet Digit Health; 2020 Aug; 2(8):e425-e434. PubMed ID: 32835200 [TBL] [Abstract][Full Text] [Related]
50. Care-home Nurses' responses to the COVID-19 pandemic: Managing ethical conundrums at personal cost: A qualitative study. Birt L; Lane K; Corner J; Sanderson K; Bunn D J Nurs Scholarsh; 2023 Jan; 55(1):226-238. PubMed ID: 36464814 [TBL] [Abstract][Full Text] [Related]
51. Public views on the Covid-19 immunity certificate: A scoping review. Barello S; Acampora M; Paleologo M; Schiavone L; Anderson G; Graffigna G Health Expect; 2022 Dec; 25(6):2645-2657. PubMed ID: 36168916 [TBL] [Abstract][Full Text] [Related]
52. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era. Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622 [TBL] [Abstract][Full Text] [Related]
53. Provide Vaccines, Not Require Immunity or Vaccination Passports … For Now. Savulescu J J Law Med Ethics; 2021; 49(2):303-306. PubMed ID: 34924044 [TBL] [Abstract][Full Text] [Related]
54. Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines? Gyngell C; Savulescu J J Med Ethics; 2021 Jun; 48(10):689-94. PubMed ID: 34172526 [TBL] [Abstract][Full Text] [Related]
55. Vaccination as an Equaliser? Evaluating COVID-19 Vaccine Prioritisation and Compensation. Günther C; Tonti L; Domenici I Med Law Rev; 2022 Dec; 30(4):584-609. PubMed ID: 36482837 [TBL] [Abstract][Full Text] [Related]
56. System dynamics analysis on the effectiveness of vaccination and social mobilization policies for COVID-19 in the United States. Chen J; Chou SY; Yu TH; Rizqi ZU; Hang DT PLoS One; 2022; 17(8):e0268443. PubMed ID: 35960739 [TBL] [Abstract][Full Text] [Related]
57. Digital Health Equity and COVID-19: The Innovation Curve Cannot Reinforce the Social Gradient of Health. Crawford A; Serhal E J Med Internet Res; 2020 Jun; 22(6):e19361. PubMed ID: 32452816 [TBL] [Abstract][Full Text] [Related]
58. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland. Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S; BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645 [TBL] [Abstract][Full Text] [Related]
59. Epistemic responsibilities in the COVID-19 pandemic: Is a digital infosphere a friend or a foe? Ćurković M; Košec A; Roje Bedeković M; Bedeković V J Biomed Inform; 2021 Mar; 115():103709. PubMed ID: 33571677 [TBL] [Abstract][Full Text] [Related]
60. Blockchain-based governance models for COVID-19 digital health certificates: A legal, technical, ethical and security requirements analysis. Foy M; Martyn D; Daly D; Byrne A; Aguneche C; Brennan R Procedia Comput Sci; 2022; 198():662-669. PubMed ID: 35103087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]